.png)

A convertible note overhang represents the trailing, compounded financial liability generated when legacy seed-stage debt instruments remain entirely unresolved as a company approaches a priced institutional financing round. Unlike Simple Agreements for Future Equity (SAFEs), which carry no maturity constraints or interest accruals , convertible notes function as rigid debt instruments with defined interest rates typically ranging between 4% and 8% annually, explicit expiration deadlines, and standard creditor default remedies. When growth-stage operators evaluate their corporate capitalization based solely on the starting principal balances of past raises , they severely miscalculate the structural mechanics of conversion, which aggregates principal and all monthly accrued interest before dividing the total by a cap or discount-adjusted per-share price. Stacking un-modeled notes over long periods allows interest blocks to quietly expand the fully diluted denominator behind the scenes, heavily inflating total dilution. Furthermore, notes lingering within a 90-day window of their maturity dates hand massive negotiating leverage to creditors , introducing sudden execution risk that can immediately compromise a clean Series B transactional framework. To isolate a capital raise from these liabilities, founders must aggressively compile a centralized debt register, model all potential scenario adjustments, and run comprehensive fully diluted stress tests at least three to four months before initiating market outreach.
The problem is not that notes will eventually convert. The problem is that unmodeled note economics, including accrued interest, stacked caps, discount rates, and MFN provisions, can materially change the cap table investors see at Series B. As detailed in what cap table issues will kill a Series B before the lead investor even reads your deck, institutional investors model total conversion economics before they engage seriously on valuation.
Key takeaways:
Most founders treat convertible notes the way they treat SAFEs: money in now, equity later, no need to think about it until the next round. That framing is wrong and it costs them in diligence.
A convertible note is a debt instrument with a principal balance, an interest rate, a maturity date, and legal consequences if it goes unresolved. Unlike a SAFE, a note can technically go into default. The investor holds creditor rights, not just a future equity claim. That legal distinction changes how investors read a note stack at Series B.
The investor concern is not whether notes exist. It is whether the team can explain total accrued interest, model conversion at multiple valuations, and show that the fully diluted count still supports a clean institutional round.
Because SAFEs now represent roughly 85 to 90 percent of U.S. pre-seed rounds, according to the WSGR Entrepreneurs Report, an old convertible note stack stands out in diligence. It signals a financing history that may have been improvised rather than planned. Investors do not automatically walk away. But they will model the note economics themselves, and if the numbers do not match what the founder presents, trust erodes before the term sheet is written.
When a qualified financing closes, a convertible note does not simply exchange the original check for shares. The conversion amount is principal plus all accrued interest to the date of closing. That total is then divided by the conversion price, which is the more favorable of the valuation cap price or the discount-adjusted round price.
The table below shows how each note term affects conversion outcomes:
The key mechanics insight is that conversion applies accrued interest before calculating share count. A founder who quotes the principal amount is describing the starting point, not the finish line. The finish line is the fully diluted count after every note converts at its actual economics.
MFN provisions add another layer. If a later note has a lower cap or a higher discount, an MFN clause can automatically reprice earlier notes to match, increasing dilution beyond what the original term sheets suggested.
Accrued interest is the most consistently underestimated component of convertible note economics. It grows every month the note remains outstanding, and it converts alongside the principal into equity at the same cap or discount. The longer the note sits, the larger the conversion amount becomes.
Here is a simplified worked example using a single $500,000 note at 6% annual interest:
The bottom line: A founder who says "we raised $500K on the note" is describing a number that no longer reflects actual conversion economics after 24 months. According to The Startup Law Blog's 2026 convertible note guide, founders frequently overlook accrued interest when projecting their fully diluted capitalization table, which leads to surprises when investors run the numbers independently.
Multiply this across three or four notes issued at different times, with different rates, and the gap between what founders expect and what investors model can be significant.
Not all note stacks carry the same risk. The ones that create real Series B friction share recognizable patterns. Understanding the hidden dilution in your SAFE stack is one part of the picture, but convertible notes and SAFEs interact in ways that can silently destroy your Series B cap table when the overhang from both instruments compounds together.
Here are the six patterns that most consistently create problems:
When a Series B investor encounters an unresolved convertible note stack, they do not just flag it as a technical issue. They use it to form a judgment about how the company has been managed.
The inference chain typically looks like this. Unresolved notes with unmodeled interest suggest the founder has not been tracking conversion economics closely. Notes approaching maturity without a resolution plan suggest reactive rather than proactive financing behavior. A stack that is hard to explain in a 10-minute conversation suggests the cap table may not be ready for institutional scrutiny at all.
Investors do not need a perfect cap table. They need a cap table the team understands completely, can model at multiple valuations, and can explain without a lawyer in the room.
Poor documentation compounds the problem. When equity records and cap table software do not agree, the friction of poor cap table documentation in a Series B data room can delay or derail a deal before a partner meeting even occurs. Note overhang that is well-modeled and cleanly documented is survivable. Note overhang that surfaces as a surprise during diligence is a different problem entirely.
The line between a manageable note stack and a live deal problem is not about size. It is about clarity, timing, and modeling completeness.
The transition from manageable to problematic usually happens gradually. A note that was fine at issuance becomes a problem as interest accrues, maturity approaches, and the cap table gets more complex. Founders rarely notice the shift because they are focused on growth, not note mechanics. Institutional investors notice immediately.
Founders raising a Series A or Series B should complete this modeling exercise before entering investor conversations. For broader context on what investors expect at each stage, the complete guide to raising capital for a startup in 2026 covers round structure and investor expectations in detail.
The note-specific modeling steps are:
Understanding how Series A valuations are calculated helps frame how conversion math changes founder ownership at different pre-money valuations.
Before entering any institutional investor conversation, confirm the following:
Before your next priced round, pull every outstanding convertible note, calculate total accrued interest at your expected closing date, model conversion shares at the cap, at the discount, and at the priced round valuation, and ask one hard question: does the fully diluted count still support a clean institutional round after every note converts? If that answer is unclear, the note overhang is already part of the deal risk.
A convertible note is a debt instrument. The investor holds a legal creditor claim against the company until the note converts or matures. A SAFE is not debt. It is a contractual right to receive equity in the future, with no maturity date, no interest, and no repayment obligation. If a startup fails to raise a qualifying round before a note's maturity date, the noteholder can demand repayment in cash. A SAFE holder cannot.
In most seed-stage convertible notes, accrued interest converts into equity alongside the principal when a qualifying financing closes. It is not paid in cash at conversion. The interest amount is added to the principal, and the combined total is used to calculate the number of shares the investor receives. This means the investor gets more equity than the principal alone would produce, which increases dilution for founders and existing shareholders.
When a convertible note reaches its maturity date without a qualifying financing, the note is technically due for repayment. The company owes the principal plus all accrued interest in cash. Most early-stage companies cannot repay. In practice, founders negotiate an extension, a forced conversion at a mutually agreed valuation, or an amendment to the note terms. According to Allied VC, failure to resolve a matured note can trigger acceleration clauses or other default remedies depending on the note agreement.
Institutional investors do not automatically reject companies with convertible note overhangs. What they react negatively to is a founder who cannot explain the note economics clearly or model the conversion outcomes at multiple valuations. An unresolved note stack that is well-documented and fully modeled is a manageable data point. An unresolved stack that surfaces as a surprise during diligence signals weak financial management.
At conversion, the investor receives the more favorable of two prices: the cap price or the discount price. The cap price is calculated by dividing the valuation cap by the fully diluted share count on a pre-money basis. The discount price is the round price reduced by the discount percentage, typically 15% to 25%. Whichever price is lower gives the investor more shares per dollar, so the investor always benefits from the more dilutive of the two mechanics.
Not automatically. Most convertible notes define a qualified financing as a priced equity round above a minimum threshold, often between $500,000 and $2 million. If the priced round is smaller than that threshold, the note may not convert automatically. The founder and noteholder would need to negotiate a voluntary conversion or an amendment. This is a common issue when a company raises a smaller bridge round that does not meet the original qualified financing definition.
Present the note stack proactively and completely. Provide a summary table showing each note's principal, interest rate, issuance date, maturity date, cap, discount, MFN status, and total accrued interest as of the expected close. Then show a fully diluted cap table that includes note conversion shares at multiple round valuations. Investors want to see that the team has already done this work, not that they are learning about it for the first time in the data room.
IRC Partners advises founders raising $5M to $250M in institutional capital on structure, positioning, and round architecture. We work with 7 strategic partners per quarter - no placement agent model, no success-only theater. If you want a structural review of your current raise, apply HERE.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.